BPG is committed to discovery and dissemination of knowledge
Original Article
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2011; 17(6): 735-742
Published online Feb 14, 2011. doi: 10.3748/wjg.v17.i6.735
Table 2 Comparison of prevalence of metabolic syndrome and its components among three groups
Group 0 (n = 274)NAFLD
Group 1 (n = 436)Group 2 (n = 151)
Age (yr)10.36 ± 2.1510.59 ± 1.8510.40 ± 2.28
Sex (M/F)187/87305/131106/45
Tanner stage (T1/T2–4)130/144209/22774/77
BMI26.88 ± 3.1928.78 ± 3.96a28.85 ± 3.69a
Hypertension68 (24.82)180 (41.28)a73 (48.34)a
Dyslipidemia42 (15.32)204 (46.78)a116 (76.82)ac
Impaired fasting glucose5 (1.82)30 (6.88)20 (13.24)ac
IGT13 (4.74)38 (8.72)18 (11.92)a
Diabetes0 (0.00)5 (1.14)7 (4.63)ac
MS33 (12.04)128 (29.36)a60 (39.74)ac


Write to the Help Desk